Home / News / Warren Buffett's Berkshire Hathway cuts stakes in U.S. drugmakers, invests in drug royalty
Listen to this article

 Warren Buffett's Berkshire Hathaway Inc said on Monday it eliminated its investment in Merck & Co and reduced its stakes in Abbvie Inc and Bristol-Myers Squibb Co, as it pared its overall stock market investments.

The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of Sept. 30.

Berkshire also disclosed new investments in Royalty Pharma Plc, which buys pharmaceutical royalties, and flooring retailer Floor & Decor Holdings Inc.


Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.
Recommended For You
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout